MVIS US Listed Biotech 25 Index

The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
United States20 83.49%
Germany1 3.70%
Ireland1 5.31%
Netherlands1 2.67%
Switzerland1 1.50%
Cayman Islands1 3.33%
Total25 100.00%
SectorComponentsWeight
Health Care25 100.00%
Total25 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap924,724,674,000 USD25 100.00%
Mid-Cap---
Small-Cap---
Micro-Cap---
Total924,724,674,000 USD25 100.00%
Up